Bio-Rad Laboratories, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Bio-Rad Laboratories, Inc. on January 10, 2023. The filing serves as a Regulation FD disclosure regarding a scheduled presentation at the 41st Annual J.P. Morgan Healthcare Conference.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces an upcoming corporate event.
Guidance, Outlook, and Management Commentary
Norman Schwartz, President and CEO, is scheduled to present a company overview at the J.P. Morgan Healthcare Conference on January 10, 2023, at 4:30 p.m. Pacific Time. The session will include a Q&A with Executive Vice President and COO Andrew Last and Executive Vice President and CFO Ilan Daskal. A live webcast and the presentation slides (Exhibit 99.1) are available on the company's Investor Relations website. The information in this filing is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the content of the J.P. Morgan Healthcare Conference presentation (Exhibit 99.1) for actual financial guidance and strategic updates.
- Confirm the live webcast availability on the Bio-Rad Investor Relations website.
- Note that this 8-K contains no audited financial data or specific earnings figures.